PBF-677

Palobiofarma SL · Phase 2 active Small molecule

At a glance

Generic name	PBF-677
Sponsor	Palobiofarma SL
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients (PHASE2)
"First-in-human" Study To Assess the Safety and Tolerability of PBF-677 in Healthy Volunteers (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PBF-677 CI brief — competitive landscape report
PBF-677 updates RSS · CI watch RSS
Palobiofarma SL portfolio CI